Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Ideaya reports preliminary phase I/II data on darovasertib in metastatic uveal melanoma

April 16, 2021

Phase II trial of TQ-B3525 for advanced gynecological cancers begins enrollment

April 16, 2021

Discovery of allosteric MALT1 protease inhibitor JNJ-67856633 for cancer

April 16, 2021

JNJ-74856665 mediates potent antileukemic activity and differentiation in preclinical models

April 16, 2021

Nanjing TransThera Biosciences presents TAM family kinase inhibitors

April 16, 2021

Betta Pharmaceuticals identifies EGFR inhibitors

April 16, 2021

Novartis divulges new EED and/or EZH2 inhibitors

April 16, 2021

FDA lifts partial clinical hold on phase I study of SBP-101 in pancreatic cancer

April 16, 2021

New target identified for treatment-resistant colorectal cancer

April 15, 2021

CDC7 inhibitor TQB-3824 shows promise in preclinical study

April 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....